메뉴 건너뛰기




Volumn 132, Issue 7, 2006, Pages 771-778

Hyaluronan and the interaction between CD44 and epidermal growth factor receptor in oncogenic signaling and chemotherapy resistance in head and neck cancer

Author keywords

[No Author keywords available]

Indexed keywords

1,4 DIAMINO 1,4 BIS(2 AMINOPHENYLTHIO) 2,3 DICYANOBUTADIENE; 4 (3 CHLOROANILINO) 6,7 DIMETHOXYQUINAZOLINE; CISPLATIN; DOXORUBICIN; EPIDERMAL GROWTH FACTOR RECEPTOR; HERMES ANTIGEN; HYALURONIC ACID; METHOTREXATE;

EID: 33746142421     PISSN: 08864470     EISSN: 08864470     Source Type: Journal    
DOI: 10.1001/archotol.132.7.771     Document Type: Article
Times cited : (127)

References (26)
  • 2
    • 0033846654 scopus 로고    scopus 로고
    • Hyaluronan is not just a goo!
    • Toole BP. Hyaluronan is not just a goo! J Clin Invest. 2000;106:335-336.
    • (2000) J Clin Invest , vol.106 , pp. 335-336
    • Toole, B.P.1
  • 3
    • 0036731866 scopus 로고    scopus 로고
    • Hyaluronan and tumor growth
    • Toole BP, Hascall VC. Hyaluronan and tumor growth. Am J Pathol. 2002;161:745-747.
    • (2002) Am J Pathol , vol.161 , pp. 745-747
    • Toole, B.P.1    Hascall, V.C.2
  • 4
    • 0037085254 scopus 로고    scopus 로고
    • Signaling properties of hyaluronan receptors
    • Turley EA, Noble PW, Bourguignon LY. Signaling properties of hyaluronan receptors. J Biol Chem. 2002;277:4589-4592.
    • (2002) J Biol Chem , vol.277 , pp. 4589-4592
    • Turley, E.A.1    Noble, P.W.2    Bourguignon, L.Y.3
  • 5
    • 0036339293 scopus 로고    scopus 로고
    • CD44 as prognostic factor in oral and oropharyngeal squamous cell carcinoma
    • Carinci F, Stabellini G, Calvitti M, et al. CD44 as prognostic factor in oral and oropharyngeal squamous cell carcinoma. J Craniofac Surg. 2002;13:85-89.
    • (2002) J Craniofac Surg , vol.13 , pp. 85-89
    • Carinci, F.1    Stabellini, G.2    Calvitti, M.3
  • 6
    • 0035404863 scopus 로고    scopus 로고
    • CD44-mediated oncogenic signaling and cytoskeleton activation during mammary tumor progression
    • Bourguignon LY. CD44-mediated oncogenic signaling and cytoskeleton activation during mammary tumor progression. J Mammary Gland Biol Neoplasia. 2001;6:287-297.
    • (2001) J Mammary Gland Biol Neoplasia , vol.6 , pp. 287-297
    • Bourguignon, L.Y.1
  • 8
    • 0035966019 scopus 로고    scopus 로고
    • Hyaluronan promotes CD44v3-Vav2 interaction with Grb2-p185HER2 and induces Rac1 and Ras signaling during ovarian tumor cell migration and growth
    • Bourguignon LY, Zhu H, Zhou B, Diedrich F, Singleton PA, Hung MC. Hyaluronan promotes CD44v3-Vav2 interaction with Grb2-p185HER2 and induces Rac1 and Ras signaling during ovarian tumor cell migration and growth. J Biol Chem. 2001;276:48679-48692.
    • (2001) J Biol Chem , vol.276 , pp. 48679-48692
    • Bourguignon, L.Y.1    Zhu, H.2    Zhou, B.3    Diedrich, F.4    Singleton, P.A.5    Hung, M.C.6
  • 9
    • 0036176638 scopus 로고    scopus 로고
    • CD44 associates with EGFR and erbB2 in metastasizing mammary carcinoma cells
    • Wobus M, Rangwala R, Sheyn I, et al. CD44 associates with EGFR and erbB2 in metastasizing mammary carcinoma cells. App Immunohistochem Mol Morphology. 2002;10:34-39.
    • (2002) App Immunohistochem Mol Morphology , vol.10 , pp. 34-39
    • Wobus, M.1    Rangwala, R.2    Sheyn, I.3
  • 10
    • 0141592701 scopus 로고    scopus 로고
    • Epidermal growth factor receptor-stimulated activation of phospholipase C-gamma-1 promotes invasion of head and neck squamous cell carcinoma
    • Thomas SM, Coppelli FM, Wells A, et al. Epidermal growth factor receptor-stimulated activation of phospholipase C-gamma-1 promotes invasion of head and neck squamous cell carcinoma. Cancer Res. 2003;63:5629-5635.
    • (2003) Cancer Res , vol.63 , pp. 5629-5635
    • Thomas, S.M.1    Coppelli, F.M.2    Wells, A.3
  • 11
    • 0043163868 scopus 로고    scopus 로고
    • EGFR family signaling and its association with breast cancer development and resistance to chemotherapy
    • Navolanic PM, Steelman LS, McCubrey JA. EGFR family signaling and its association with breast cancer development and resistance to chemotherapy (Review). Int J Oncol. 2003;22:237-252.
    • (2003) Int J Oncol , vol.22 , pp. 237-252
    • Navolanic, P.M.1    Steelman, L.S.2    McCubrey, J.A.3
  • 12
    • 0036342722 scopus 로고    scopus 로고
    • EGF receptor modifies cellular responses to hyaluronan in glioblastoma cell lines
    • Tsatas D, Kanagasundaram V, Kaye A, Novak U. EGF receptor modifies cellular responses to hyaluronan in glioblastoma cell lines. J Clin Neurosci. 2002;9:282-288.
    • (2002) J Clin Neurosci , vol.9 , pp. 282-288
    • Tsatas, D.1    Kanagasundaram, V.2    Kaye, A.3    Novak, U.4
  • 13
    • 0037215106 scopus 로고    scopus 로고
    • Targeting epidermal growth factor receptor in head and neck cancer
    • Ford AC, Grandis JR. Targeting epidermal growth factor receptor in head and neck cancer. Head Neck. 2003;25:67-73.
    • (2003) Head Neck , vol.25 , pp. 67-73
    • Ford, A.C.1    Grandis, J.R.2
  • 14
    • 0036462583 scopus 로고    scopus 로고
    • EGF receptor targeting in therapy-resistant human tumors
    • Schmidt M, Lichtner RB. EGF receptor targeting in therapy-resistant human tumors. Drug Resist Updat. 2002;5:11-18.
    • (2002) Drug Resist Updat , vol.5 , pp. 11-18
    • Schmidt, M.1    Lichtner, R.B.2
  • 15
    • 25844481618 scopus 로고    scopus 로고
    • Intrinsic and acquired resistance to EGFR inhibitors in human cancer therapy
    • Bianco R, Troiani T, Tortora G, Fortunato C. Intrinsic and acquired resistance to EGFR inhibitors in human cancer therapy. Endocr Relat Cancer. 2005;12:S159-S171.
    • (2005) Endocr Relat Cancer , vol.12
    • Bianco, R.1    Troiani, T.2    Tortora, G.3    Fortunato, C.4
  • 17
    • 0037063999 scopus 로고    scopus 로고
    • Hyaluronan oligosaccharides inhibit anchorage-independent growth of tumor cells by suppressing the phosphoinositide 3-kinase/Akt cell survival pathway
    • Ghatak S, Misra S, Toole B. Hyaluronan oligosaccharides inhibit anchorage-independent growth of tumor cells by suppressing the phosphoinositide 3-kinase/Akt cell survival pathway. J Biol Chem. 2002;277:38013-38020.
    • (2002) J Biol Chem , vol.277 , pp. 38013-38020
    • Ghatak, S.1    Misra, S.2    Toole, B.3
  • 18
    • 0037478612 scopus 로고    scopus 로고
    • Regulation of multi-drug resistance in cancer cells by hyaluronan
    • Misra S, Ghatak S, Zoltan-Jones A, Toole B. Regulation of multi-drug resistance in cancer cells by hyaluronan. J Biol Chem. 2003;278:25285-25288.
    • (2003) J Biol Chem , vol.278 , pp. 25285-25288
    • Misra, S.1    Ghatak, S.2    Zoltan-Jones, A.3    Toole, B.4
  • 19
    • 0035393501 scopus 로고    scopus 로고
    • CD44 survival pathway triggers chemoresistance via lyn kinase and phosphoinositide 3-kinase/Akt in colon carcinoma cells
    • Bates RC, Edwards NS, Burns GF, Fisher DEA. CD44 survival pathway triggers chemoresistance via lyn kinase and phosphoinositide 3-kinase/Akt in colon carcinoma cells. Cancer Res. 2001;61:5275-5283.
    • (2001) Cancer Res , vol.61 , pp. 5275-5283
    • Bates, R.C.1    Edwards, N.S.2    Burns, G.F.3    Dea, F.4
  • 20
    • 0034763605 scopus 로고    scopus 로고
    • CD44 mediates constitutive type 1 receptor signaling in cervical carcinoma cells
    • Wobus M, Kuns R, Wolf C, et al. CD44 mediates constitutive type 1 receptor signaling in cervical carcinoma cells. Gynecol Oncol. 2001;83:227-234.
    • (2001) Gynecol Oncol , vol.83 , pp. 227-234
    • Wobus, M.1    Kuns, R.2    Wolf, C.3
  • 21
    • 0033673670 scopus 로고    scopus 로고
    • Epidermal growth factor upregulates CD44-dependent astrocytoma invasion in vitro
    • Monaghan M, Mulligan KA, Gillespie H, et al. Epidermal growth factor upregulates CD44-dependent astrocytoma invasion in vitro. J Pathol. 2000;192:519-525.
    • (2000) J Pathol , vol.192 , pp. 519-525
    • Monaghan, M.1    Mulligan, K.A.2    Gillespie, H.3
  • 22
    • 15744404625 scopus 로고    scopus 로고
    • Hyaluronan-CD44 interaction with IQGAP1 promotes Cdc42 and ERK signaling, leading to actin binding, Elk-1/estrogen receptor transcriptional activation, and ovarian cancer progression
    • Bourguignon LY, Gilad E, Rothman K, Peyrollier K. Hyaluronan-CD44 interaction with IQGAP1 promotes Cdc42 and ERK signaling, leading to actin binding, Elk-1/estrogen receptor transcriptional activation, and ovarian cancer progression. J Biol Chem. 2005;280:11961-11972.
    • (2005) J Biol Chem , vol.280 , pp. 11961-11972
    • Bourguignon, L.Y.1    Gilad, E.2    Rothman, K.3    Peyrollier, K.4
  • 23
    • 0041342137 scopus 로고    scopus 로고
    • P53 mutation correlates with cisplatin sensitivity in head and neck squamous cell carcinoma lines
    • Bradford CR, Zhu S, Ogawa H, et al. P53 mutation correlates with cisplatin sensitivity in head and neck squamous cell carcinoma lines. Head Neck. 2003;25:654-661.
    • (2003) Head Neck , vol.25 , pp. 654-661
    • Bradford, C.R.1    Zhu, S.2    Ogawa, H.3
  • 24
    • 0346365372 scopus 로고    scopus 로고
    • Glutathione S-transferase amplification is associated with cisplatin resistance in head and neck squamous cell carcinoma cell lines and primary tumors
    • Cullen KJ, Newkirk KA, Schumaker LM, Aldosari N, Rone JD, Haddad BR. Glutathione S-transferase amplification is associated with cisplatin resistance in head and neck squamous cell carcinoma cell lines and primary tumors. Cancer Res. 2003;63:8097-8102.
    • (2003) Cancer Res , vol.63 , pp. 8097-8102
    • Cullen, K.J.1    Newkirk, K.A.2    Schumaker, L.M.3    Aldosari, N.4    Rone, J.D.5    Haddad, B.R.6
  • 25
    • 0033844889 scopus 로고    scopus 로고
    • Prognostic value of c-erbB2 and other markers in patients treated with chemotherapy for recurrent head and neck cancer
    • Shiga H, Rasmussen AA, Johnston PG, et al. Prognostic value of c-erbB2 and other markers in patients treated with chemotherapy for recurrent head and neck cancer. Head Neck. 2000;22(6):599-608.
    • (2000) Head Neck , vol.22 , Issue.6 , pp. 599-608
    • Shiga, H.1    Rasmussen, A.A.2    Johnston, P.G.3
  • 26
    • 0036732010 scopus 로고    scopus 로고
    • Overexpression of wild-type breast cancer resistance protein mediates methotrexate resistance
    • Volk EL, Farley KM, Wu Y, Li F, Robey RW, Schneider E. Overexpression of wild-type breast cancer resistance protein mediates methotrexate resistance. Cancer Res. 2002;62:5035-5040.
    • (2002) Cancer Res , vol.62 , pp. 5035-5040
    • Volk, E.L.1    Farley, K.M.2    Wu, Y.3    Li, F.4    Robey, R.W.5    Schneider, E.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.